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Abstract
Background: This study aimed to identify predictors of early (7-day) mortality in patients with septic acute kidney
injury (AKI) who required continuous renal replacement therapy (CRRT).
Methods: Prospective cohort of 186 septic AKI patients undergoing CRRT at a tertiary hospital, from October 2005
to November 2010.
Results: After multivariate adjustment, five variables were associated to early mortality: norepinephrine utilization, liver
failure, medical condition, lactate level, and pre-dialysis creatinine level. These variables were combined in a score,
which demonstrated good discrimination, with a C-statistic of 0.82 (95% CI = 0.76–0.88), and good calibration (χ2 = 4.3;
p = 0.83). SAPS 3, APACHE II and SOFA scores demonstrated poor performance in this population.
Conclusions: The HEpatic failure, LactatE, NorepInephrine, medical Condition, and Creatinine (HELENICC) score
outperformed tested generic models. Future studies should further validate this score in different cohorts.
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Background
Sepsis and septic shock are the most common and se-
vere causes of morbidity and mortality among critically
ill patients [1]. Septic acute kidney injury (AKI) is one of
the most life-threatening manifestations of sepsis [2, 3].
Septic AKI is associated with a high burden of illness,
increased abnormalities in acute physiology and labora-
tory findings, and higher rates of non-renal organ failure
and renal replacement therapy. Additionally, AKI has
been shown to be independently associated with worse
patient outcomes and increased health care costs [4].
Severity scores and risk stratification have been incor-
porated into the management of patients with AKI [5],
because estimated probabilities of hospital mortality may
provide important information for clinical decision-
making [6], such as informing prognosis to patient and
carers, discussions of goal-of-care, decisions about re-
source allocation and assessments of the quality of care
that has been provided [6, 7]. However, it has been ar-
gued that general physiological scores may not have the
same accuracy along the extended range of critical ill-
nesses [8] and most general prognostic tools lack pre-
dictive accuracy or show great variability when applied
to patients with AKI [9–12]. So, disease-specific scores
have been developed in critically ill patients with AKI
[13], but there are few data concerning the assessment
of the severity of illness in septic AKI patients who
undergo continuous renal replacement therapy (CRRT).
In this study, we aimed to identify predictors of early
(7-day) mortality in septic critically ill patients undergo-
ing CRRT. We also aimed to create a severity assessment
tool capable of predicting the early mortality risk of
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septic critically ill patients at the start of CRRT and
compare its performance with the performance of
three generic scores (i.e., Simplified Acute Physiology
Score [SAPS 3], Acute Physiology and Chronic Health
Enquiry [APACHE II], and Sequential Organ Failure
Assessment [SOFA]).
Methods
This study was approved by the ethics committee at
Hospital Português. Informed consent was waived be-
cause data were collected routinely and statistical ana-
lyses were performed anonymously.
Study design and patient population
This prospective cohort study was conducted in three dif-
ferent intensive care units (cardiac, medical, and surgical
units) at Hospital Portugues, a Brazilian tertiary hospital,
from October 2005 to November 2010. All consecutive
adult patients with septic AKI (as defined below) that
would be submitted to continuous renal replacement ther-
apy (CRRT), as indicated by the medical team, were in-
cluded in the study. Patients expected to die in the
following 24-h from the admission or patients that had
limitation of medical therapies orders would not be candi-
dates to CRRT and would not be included in the study. In
the event of multiple admissions, only the first intensive
care unit (ICU) admission was analyzed.
Definitions
AKI was classified according to the Acute Kidney Injury
Network (AKIN) criteria. Serum creatinine values were ad-
justed according to cumulative fluid balance from ICU ad-
mission, as described below. Sepsis was defined according
to the International Sepsis Definitions Conference recom-
mendations [14]. Septic AKI was defined as the simultan-
eous presence of both syndromes, sepsis and AKI, in the
absence of other clear and established non-sepsis-related
precipitants of AKI (i.e., urinary tract obstruction, radio
contrast media, and other nephrotoxins). Comorbidity in-
formation was determined from the International Classifi-
cation of Diseases (ninth revision) codes used upon
admission [15]. Medical condition was defined as a medical
(i.e., non-surgical) reason for admission in the ICU.
The primary endpoint was defined as early (7-day)
mortality.
Data collection
Patients’ demographics, primary diagnosis, and associated
comorbidities were recorded at ICU entry. Demographic
information included the patient’s age, sex, and admission
dates. Clinical data comprised the source of infection,
microbiological data, antibiotic use, fluid balance, need for
mechanical ventilation, and use of vasopressor drugs
(norepinephrine). Physiological data included the Glasgow
Coma Scale score, vital signs, the arterial oxygen tension/
fraction of inspired oxygen (PaO2/FiO2) ratio, and serum
pH, sodium, potassium, bilirubin, hematocrit, and white
blood cell count levels. Kidney function data included
serum creatinine and urea levels, and urine output. Sever-
ity of illness was assessed on the day of the initiation of
CRRT using the APACHE II, SAPS 3, and SOFA scores.
Correction of serum creatinine for fluid balance
Admission weights were available in all patients. Daily
fluid balance was determined from all intakes and out-
puts recorded. No correction was made for insensible
losses. Cumulative fluid balance was computed by sum-
ming the daily fluid balances. Serum creatinine (sCr)
values were adjusted according to the cumulative daily
fluid balance using the formula [16, 17]:
adjusted creatinine ¼ sCr correction factor:
Correction factor ¼ ðhospital admission weight kgð Þ
 0:6þ Σ daily cumulative fluid balance Lð Þð ÞÞ
=hospital admission weight  0:6:
CRRT procedure
CRRT was provided as continuous venous-venous
hemodiafiltration (CVVHDF) and was started by con-
sulting nephrologists based on standard clinical guide-
lines, including AKI with hemodynamic instability,
ongoing hypercatabolism, hyperkalemia, severe acidosis,
volume overload, respiratory distress, multiorgan failure
or some combination of these factors. Saline flushes
were used to maintain filter patency, instead of heparin.
Patients were routinely treated by CVVHDF with bicar-
bonate buffered solution. The procedure was performed
using the Gambro PRISMA continuous renal replace-
ment therapy (CRRT) machine. In all patients, a M100
hemofilter was used and was routinely changed after
72 h. The ultrafiltrate flow rate was set accordingly daily
fluid balance gains. The prescribed dialysis dose was
around 20 a 30 ml/kg/h, as per institutional protocol.
Statistical analysis
Statistical analysis was performed using IBM SPSS® Sta-
tistics version 18.0. Continuous variables are expressed
as the mean (SD) or median and interquartile range, and
were analyzed using the unpaired t-test or the Wilcoxon
rank-sum test, as appropriate. Categorical variables are
expressed as the absolute (n) and relative (%) frequency,
and were analyzed using the chi-squared test or Fisher’s
exact test, as appropriate. Data are presented with 95%
confidence intervals (CIs) and p < 0.05 was considered to
be statistically significant for all comparisons.
A logistic regression model was constructed to evalu-
ate variables independently associated to 7-day mortality
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and for the construction of a prediction score. Initially,
univariate analysis was performed to identify variables
associated with 7-day mortality. Variables associated to
early mortality with a p value <0.10 in univariate analysis
were selected for logistic regression analysis, which was
performed by a stepwise procedure with backward elim-
ination using Wald statistic. The independent predictors
of mortality at a 5% significance level were used to build
a risk score. The risk score was built by assigning points
to each variable, corresponding to their odds ratio,
multiplied by 2, and rounded to the nearest integer. To
describe the predictive value of the score, C-statistics
were used for discrimination and the Hosmer-
Lemeshow test was used for calibration. We also ana-
lyzed the area under the receiver operating characteristic
curve to evaluate the performance of the score, as com-
pared to the other generic predictive scores.
Results
Description of the cohort
From October, 2005 to November, 2010, 186 septic AKI
patients undergoing CVVHDF were enrolled in the
study. There were 84 (45%) patients in the surgical ICU,
61 (33%) patients in the medical ICU and 41 (22%) pa-
tients in the cardiac ICU. Mean age ± SD was 68.7 ±
14.6 years and 104 (56%) patients were male. The most
common source of infection was pulmonary infection
(56% of patients), followed by bloodstream infection in
16% of patients. Hospital acquired sepsis accounted for
74% the cases and community acquired sepsis for 26%.
On the day of CRRT initiation, mean ± SD for SAPS 3,
APACHE II, and SOFA scores were 74.1 ± 9.9, 28.5 ± 8.3,
and 12.7 ± 2.4, respectively. Mortality at 7 days was 45%
(84 patients).
Characteristics associated to 7-day mortality
In univariate analysis of the clinical and laboratory char-
acteristics, nine variables were associated with 7-day
mortality at the 10% significance level: liver failure, heart
failure, medical condition, norepinephrine utilization,
pre-dialysis lactate level, sodium level, potassium level,
creatinine level, and platelet count (Table 1).
After multivariate analysis, five variables remained sig-
nificantly associated to mortality (Table 2): norepineph-
rine utilization, liver failure, medical condition, lactate
and pre-dialysis creatinine. This final model had a sig-
nificant C-statistic of 0.82 (95% CI = 0.76–0.88) and
good calibration (χ2 = 4.3; p = 0.83).
Score development and performance evaluation
Based on the magnitude of regression coefficients in the
multivariate analysis, we created the HEpatic failure,
LactatE, NorepInephrine, medical Condition, and Cre-
atinine (HELENICC) score. Score points were attributed
proportionally to the odds ratio for each variable, thereby
generating a scoring system. Medical condition, liver fail-
ure, and norepinephrine utilization each added 6 points,
and 3 points was added for each unit of lactate. Two points
were subtracted for each unit of creatinine. The scoring
system was derived as follows: (medical condition × 6)
+ (liver failure × 6) + (norepinephrine × 6) + (lactate × 3)
− (creatinine × 2).
The HELENICC score was linearly associated to mortal-
ity (chi-square for trend, p <0.001), as seen in Fig. 1, with
each increasing score quartile being associated to mo-
rtality with an OR (95% CI) of 3.15 (2.29–4.45). The score
also demonstrated good discrimination, with an area
under the ROC curve of 0.82 (95% CI = 0.76–0.88; p <
0.001), (Fig. 2). This performance was better than that of
the generic scores, as the area under the receiver operat-
ing characteristic (ROC) curve was not significant for
SAPS 3 (area under the curve [AUC] = 0.48; 95% CI =
0.40–0.57; p = 0.08), APACHE II (AUC= 0.57; 95% CI =
0.48–0.66; p = 0.10), or SOFA (AUC = 0.58; 95% CI =
0.49–0.66; p = 0.58) (Fig. 2).
Discussion
In this prospective cohort of 186 critically ill patients
with septic AKI undergoing CRRT, norepinephrine use,
lactate, liver failure, medical condition and pre-dialysis
creatinine were independently associated to 7-day mor-
tality. Those characteristics were used to build a scoring
system to predict early mortality (the HELENICC score),
which demonstrated good discrimination and calibration
and outperformed generic scoring systems in this
population.
The HELENICC score modeling identified five inde-
pendent variables (norepinephrine utilization, medical
condition, liver failure, pre-dialysis lactate, and creatinine)
that were associated with mortality, allowing the assess-
ment of septic AKI requiring CRRT. The HELENICC
score demonstrated good calibration, as assessed by the
Hosmer-Lemeshow statistic, and was linearly associated
to mortality with an odds ratio for mortality of approxi-
mately 3 for each increased quartile. Moreover, the HELE-
NICC score demonstrated good discrimination, with an
area under the ROC curve of 0.82, which was better than
the other generic scores tested.
Even more, this score reflects the same stage of disease
progression, and it was performed on the day of CRRT
initiation, as carried out in previous studies [9, 11].
Another study on a large and diverse AKI population
spanning three hospitals in a health system and including
all patients regardless of their ICU, surgical, or medical
status, showed that a small group of easily measured
clinical factors had good ability to predict mortality and
the need for dialysis in severe AKI [18]. As with the
HELENIC score, this previous study identified strong
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predictors (e.g., intensive care unit location, medical ser-
vice, liver disease, creatinine level and value variation, and
greater number of pressor medications) of the combined
endpoint of dialysis or death within 14 days [18].
A potential strength of the new score is its simplicity.
This score is based on easily available variables, all with
known effects on AKI mortality, and allows risk stratifica-
tion of patients into different severity levels with progres-
sive rates of mortality. There are important theoretical
advantages to disease-specific predictive models [9]. The
application of generic severity scores in specific cohorts,
such as in patients with septic AKI, is challenging because
of relatively poor discrimination and suboptimal calibration
[19]. Almost all generic severity scores include “points” for
AKI; in an AKI cohort, these points are equally assigned to
all patients, limiting the value of the information [20, 21].
In fact, all generic models tested (i.e., APACHE II, SAPS, 3
and SOFA) in the present study showed similar perform-
ance levels, but significantly underestimated the mortality
rate. Uchino et al. [5] showed the same results as in our
Table 1 Association of clinical characteristics and 7-day mortality in the cohort
Non Survivors Survivors p value
(n = 84) (n = 102)
Age (years), mean ± SD 67 ± 16 70 ± 13 0.14
Male sex, n (%) 42 (50%) 62 (61%) 0.14
Medical condition, n (%) 57 (68%) 50 (49%) 0.01
Primary site of infection, n (%)
Pulmonary 49 (58%) 55 (54%) 0.55
Urinary 6 (7.1%) 9 (8.8%) 0.68
Abdominal 8 (9.5%) 12 (12%) 0.62
BSI a 14 (17%) 15 (15%) 0.71
CRBSI b 5 (6.0%) 11 (1%) 0.24
SSTIs c 2 (2.4%) 0 0.20
Comorbidities, n (%)
Heart failure 28 (33%) 50 (49%) 0.03
Coronary artery disease 25 (30%) 42 (41%) 0.11
Pulmonary disease 8 (9.5%) 10 (9.8%) 1.0
Liver failure 55 (66%) 32 (31%) <0.001
Cerebral vascular disease 7 (8.3%) 8 (7.8%) 0.90
Diabetes 23 (27%) 37 (36%) 0.20
Norepinephrine use 78 (93%) 80 (78%) 0.006
Admission creatinine (mg/dl), median (IQR) 1.0 (0.8–1.6) 1.2 (0.9–2.2) 0.14
Laboratory values before RRT d, median (IQR)
Urea (mg/dl) 142 (86–198) 137 (78–206) 0,57
Chloride (mmol/l) 109 (104–112) 107 (104–110) 0,41
Creatinine (mg/dl) 2.2 (1.5–3.3) 2.7 (2.0–3.8) 0.005
Potassium (mmol/l) 4.7 (3.8–5.4) 4.3 (3.8–5.0) 0.05
Sodium (mmol/l) 133 (127–137) 135 (132–139) 0.009
Lactate (mmol/l) 3.0 (1.8–5.1) 1.8 (1.4–2.7) <0.001
Hemoglobin (g/dl) 8.9 (8.0–9.9) 9.1 (8.2–10) 0.21
White cell count (103 mm3/l) 17 (6.6–24) 16 (11–22) 0.64
Platelets count (103 mm3/l) 94 (48–176) 155 (79–265) 0.001
24 h urinary output (ml/kg/h) 320 (150–600) 300 (100–600) 0.57
Fluid Balance (ml) 7782 (4175–11,389) 6891 (4090–9692) 0.007
aBSI bloodstream infections
bCRBSI cateter-related bloodstream infections
cSSTIs skin and soft tissue infections
dRRT renal replacement therapy
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study after testing two general scoring systems (SAPS II
and SOFA) in a cohort of 1742 intensive care unit patients
from multiple countries with AKI. These patients were ei-
ther treated with renal replacement therapy or fulfilled the
predefined criteria. In their study, none of the tested scor-
ing systems demonstrated a high level of discrimination or
calibration for predicting mortality in patients with AKI [5].
Other studies demonstrated variable results. Douma et al.
[10] showed that the predictive abilities of several mortality
prediction models varied widely when applied to AKI pa-
tients undergoing dialysis. Costa e Silva et al. [11] reported
that the Simplified Acute Physiology Score (SAPS) 3 was
the most accurate scoring system among third generation
models for predicting hospital mortality in AKI. In a cohort
of critically ill dialytic AKI patients, Maccariello et al. [12]
showed that the SAPS 3 accurately predicted hospital mor-
tality at the start of renal replacement therapy.
In our population, we decided to study early mortality
(7-day mortality) from the beginning of CRRT, because
our patients were severely ill, with high APACHE II scores
and SAPS 3, as well as high organ dysfunctions as mea-
sured with the SOFA score. This severity was associated
with high early mortality and such risk assessment is im-
portant to help inform the clinicians, patients and surro-
gates involved in the patient care. Our mortality results
are consistent with the results of a large multicenter ob-
servational cohort [22]. In this cohort, Bagshaw et al. [22]
described the characteristics and investigated the clinical
outcomes of septic and non-septic AKI critically ill
patients. Septic AKI was associated with a greater burden
of illness, as shown by the severity-of-illness scores, con-
comitant non-renal organ dysfunction, need for mechan-
ical ventilation, and proportion of patients who required
vasoactive therapy. In their study, septic AKI was associ-
ated with a higher crude in-hospital case-fatality rate than
non-septic AKI (70.2% versus 51.8%; relative risk, 1.35;
95% CI = 1.3–1.5; p < 0.001) [22].
In our study, higher creatinine levels at the start of
CRRT showed a protective effect. Cerdá et al. [23] ob-
tained the same results as in our study in a cohort of
134 critically ill patients with AKI who required CRRT.
Multivariate logistic regression analysis detected a rela-
tionship between a higher serum creatinine level at
CRRT initiation and improved survival rate (odds ratio,
1.48: 95% CI = 1.034–1.999) [23]. To avoid the probable
effect of fluid balance on serum creatinine levels, we cor-
rected creatinine levels using the formula suggested by
Macedo et al. [17]. In a cohort of 253 patients recruited
from a prospective observational study of critically ill pa-
tients with AKI, they showed that dilution of creatinine
by fluid accumulation may lead to underestimation of
the severity of AKI and increase the time required to
identify a 50% relative increase in creatinine levels.
Our study has several limitations. Recently, the third
international consensus for sepsis and septic shock has
been proposed [24] with new definitions for those syn-
dromes. However, even though our data was collected
before the release of this consensus, our inclusion cri-
teria of septic patients as patients with infection and a
new infection-related organ dysfunction (i.e., acute kid-
ney injury) is in agreement with those new definitions.
Other limitation is that there were no data for assessing
compliance to early goal directed therapy, or any other
measures of processes of care, in this group of patients
before or during CRRT, which can biases our results. For
example, Plataki et al. [25] reported that, in a cohort of
390 patients with septic shock admitted to a medical
ICU, patients and health care delivery risk factors ap-
peared to be important factors for the development of
AKI. Even more, our database did not include any data
on the exact indications, and the rate of ultrafiltration
and timing for CVVHDF.
Moreover, although the same medical team cared for
all patients in this study, there was inevitable day-to-day
variation in the practitioners who were in charge of the
patients. These changes in the process of care might
have induced some variability in the quality of care,
which could have caused a degree of bias in the results.
For example, there were no objective criteria for initi-
ation of CRRT and there has been wide controversies
about the benefits of early versus delayed initiation of
renal replacement therapy in critically ill patients [26],
especially after the publication of two large randomized
Fig. 1 Seven-day mortality (%) in each of HELENICC score’s quartiles
(chi-square for trend, p < 0.001)
Table 2 Multivariate analysis of characteristics associated to 7-
day mortality
Variable B OR (95% CI) p value
Norepinephrine use 1.116 3.1 (1.1–8.7) 0.038
Lactate (mmol/l) 0.480 1.6 (1.3–2.1) <0.001
Pre-dialysis creatinine (mg/dl) −0.337 0.71 (0.55–0.93) 0.013
Liver failure 0.978 2.7 (1.3–5.4) 0.007
Medical condition 0.988 2.7 (1.3–5.6) 0.008
da Hora Passos et al. BMC Anesthesiology  (2017) 17:21 Page 5 of 8
controlled trials with divergent results [27, 28]. So, it
is possible that the HELENICC score may perform
differently in patients submitted to early or delayed
initiation of renal replacement therapy. However, al-
though we lack specific data, based on the routine in-
dications for CRRT in our service, it is reasonable to
infer that most patients in this study would have been
classified as delayed initiation of renal replacement
therapy in the ELAIN trial [27], although many of
them might have been classified as early initiation in
the AIKIKI trial [28].
Furthermore, because we aimed to analyze early (7-
day mortality), we did not present data on long term
mortality or other relevant functional outcomes, so there
is no information on the performance of the score for
those outcomes. Additionally, as with any probabilistic
score, the use of such probabilities to assess prognosis
for individual patients demands caution, especially when
such predictions may have an impact on the provision of
care to the individual patients, because of the high level
of uncertainty implicated on such analyzes [6]. Finally,
although this score has been prospectively developed at
our institution in three different ICUs, this was a single-
center study with limited generalizability and this model
or any such predictive model should be independently
validated in other populations and at any other institu-
tions that propose its use.
Conclusion
In summary, in this study we developed a scoring system
that accurately predicts 7-day mortality. This model out-
performed generic models in this population. Future
studies should further validate this score in different
cohorts.
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